Industry Insights

Stay up to date with all the latest industry insights for the life sciences, medical, outsourcing and medical recruitment industry, with CHASE.

Faster access to medicines: What the NICE and MHRA partnership means for pharma, medtech, and the NHS

The UK is accelerating medicine access. We break down the new NICE-MHRA partnership and what it means for launch excellence, patient pathways, and NHS strategy.

August 20, 2025

Industry Insights

How the NHS Genomics Programme will work

The NHS’s £650m genomics expansion will transform care, enabling newborn screening and lifelong data use - reshaping strategy for life sciences professionals.

Industry Insights

Understanding the Model ICB Blueprint

Discover how the NHS is transforming with the Model Integrated Care Board Blueprint. The document lays the groundwork for how ICBs must evolve to meet needs.

Industry Insights

How to market pharmaceuticals to dispensing doctors

Discover how to market pharmaceuticals to dispensing doctors. Learn their challenges and strategies to boost adoption, prescriber relations and outcomes.

Industry Insights

ABPI Conference 2025: Key Takeaways for pharma and NHS professionals

CHASE covers the ABPI 2025 Conference, highlighting key insights from UK life sciences leaders on health, growth and renewal shaping the sector’s future.

Industry Insights

Big changes ahead for the UK pharma sector as Government reshapes National Healthcare

UK healthcare and pharmaceutical industries are on the cusp of change, with a series of recent government announcements set to reshape structures and processes.

Industry Insights

UK drug rebate rise and VPAG: A perfect storm for pharma

UK pharma faces major changes as the Statutory Scheme payment rate rises from 15.5% to 32.2% in 2025, impacting pricing, access and growth strategies.

Industry Insights

What the UK health and life sciences sector thinks about the recent budget

CHASE analysed 41,500+ online opinions on the UK budget’s impact on healthcare, NHS, and pharma, uncovering 7 key themes from stakeholders and influencers.

Industry Insights

ABPI Conference 2024: Navigating a path to stability and innovation in UK pharma

CHASE attended ABPI Conference 2024, discussing UK life sciences, innovation, regulation and investment to support pharma’s growth and industry stability.

Industry Insights

ARRS: Successes, impacts, and the future

ARRS has delivered 50M+ appointments and 34k+ new staff, easing GP pressure. Learn how NHS plans to expand ARRS funding and improve primary care through 2025.

Industry Insights

Most common questions from Clinical Pharmacy Congress 2023

Common questions from Clinical Pharmacy Congress 2023: How to start in pharma, career paths, networking tips, and where to find current vacancies with CHASE.

Industry Insights